Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$133.4m reported value -6.4% vs Q4 2023
10positions
100.0%in top 10
1 new 2 added 5 reduced 0 sold out vs Q4 2023

Holdings, Q1 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 908,474 $26.0m19.47% 19.47% UnchangedShares held: Q2 2023 858.5k, Q3 2023 908.5k, Q4 2023 908.5k, Q1 2024 908.5k
2 REGENXBIO INC COM RGNX RGNX 906,248 $19.1m14.31% 14.31% AddedShares held: Q2 2023 870.1k, Q3 2023 847.4k, Q4 2023 802.4k, Q1 2024 906.2k +103.8k +103,824 12.9%
3 BLUEPRINT MEDICINES CORP COM BPMC BPMC 182,151 $17.3m12.95% 12.95% ReducedShares held: Q2 2023 449.0k, Q3 2023 379.1k, Q4 2023 254.8k, Q1 2024 182.2k -72.7k -72,676 -28.5%
4 ARVINAS INC COM ARVN ARVN 405,766 $16.8m12.55% 12.55% ReducedShares held: Q2 2023 623.9k, Q3 2023 489.2k, Q4 2023 489.2k, Q1 2024 405.8k -83.4k -83,387 -17.1%
5 KYMERA THERAPEUTICS INC COM KYMR KYMR 388,743 $15.6m11.71% 11.71% ReducedShares held: Q2 2023 651.3k, Q3 2023 782.2k, Q4 2023 881.3k, Q1 2024 388.7k -492.6k -492,594 -55.9%
6 SILENCE THERAPEUTICS PLC ADS SLN SLN 574,214 $12.4m9.30% 9.30% ReducedShares held: Q2 2023 1.3m, Q3 2023 1.3m, Q4 2023 1.0m, Q1 2024 574.2k -469.1k -469,070 -45.0%
7 MERUS N V COM MRUS MRUS 255,109 $11.5m8.61% 8.61% ReducedShares held: Q2 2023 775.1k, Q3 2023 430.1k, Q4 2023 355.1k, Q1 2024 255.1k -100.0k -100,000 -28.2%
8 SUTRO BIOPHARMA INC COM COM 1,165,466 $6.6m4.94% 4.94% AddedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 420.6k, Q1 2024 1.2m +744.8k +744,817 177.1%
9 PRECISION BIOSCIENCES INC COM NEW DTIL DTIL 385,440 $5.2m3.92% 3.92% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 385.4k
10 REPARE THERAPEUTICS INC COM RPTX RPTX 633,271 $3.0m2.24% 2.24% UnchangedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 633.3k, Q1 2024 633.3k